MIRA
INFORM REPORT
|
Name :
|
PHARMA-RX CHEMICAL CORPORATION
|
|
|
|
|
Registered Office :
|
300 Interpace
Parkway, Ste 150, Parsippany, NJ 07054
|
|
|
|
|
Country :
|
United States
|
|
|
|
|
Date of Incorporation :
|
01.02.1991
|
|
|
|
|
Legal Form :
|
Corporation – Profit
|
|
|
|
|
Line of Business :
|
Subject is engages in marketing and distribution of chemicals in the pharmaceutical
and dietary supplement industries.
|
|
|
|
|
No. of Employees :
|
4
|
|
RATING
|
STATUS
|
PROPOSED CREDIT LINE
|
|
41-55
|
Ba
|
Overall operation is considered normal. Capable to meet normal
commitments.
|
Satisfactory
|
|
|
|
|
|
Status :
|
Satisfactory
|
|
|
|
|
Payment Behaviour :
|
No Complaints
|
|
|
|
|
Litigation :
|
Clear
|
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2014
|
Country Name
|
Previous Rating
(30.06.2014)
|
Current Rating
(30.09.2014)
|
|
United States
|
A1
|
A1
|
|
Risk Category
|
ECGC
Classification
|
|
Insignificant
|
A1
|
|
Low
|
A2
|
|
Moderate
|
B1
|
|
High
|
B2
|
|
Very High
|
C1
|
|
Restricted
|
C2
|
|
Off-credit
|
D
|
UNITED STATES - ECONOMIC
OVERVIEW
The US has the
largest and most technologically powerful economy in the world, with a per
capita GDP of $49,800. In this market-oriented economy, private individuals and
business firms make most of the decisions, and the federal and state
governments buy needed goods and services predominantly in the private
marketplace. US business firms enjoy greater flexibility than their
counterparts in Western Europe and Japan in decisions to expand
capital plant, to lay off surplus workers, and to develop new products. At the
same time, they face higher barriers to enter their rivals' home markets than
foreign firms face entering US
markets. US firms are at or near the forefront in technological advances,
especially in computers and in medical, aerospace, and military equipment;
their advantage has narrowed since the end of World War II. The onrush of
technology largely explains the gradual development of a "two-tier labor
market" in which those at the bottom lack the education and the
professional/technical skills of those at the top and, more and more, fail to
get comparable pay raises, health insurance coverage, and other benefits. Since
1975, practically all the gains in household income have gone to the top 20% of
households. Since 1996, dividends and capital gains have grown faster than
wages or any other category of after-tax income. Imported oil accounts for
nearly 55% of US
consumption. Crude oil prices doubled between 2001 and 2006, the year home
prices peaked; higher gasoline prices ate into consumers' budgets and many
individuals fell behind in their mortgage payments. Oil prices climbed another
50% between 2006 and 2008, and bank foreclosures more than doubled in the same
period. Besides dampening the housing market, soaring oil prices caused a drop
in the value of the dollar and a deterioration in the US merchandise Trade deficit, which peaked at $840 billion in
2008. The sub-prime mortgage crisis, falling home prices, investment bank
failures, tight credit, and the global economic downturn pushed the United States
into a recession by mid-2008. GDP contracted until the third quarter of 2009,
making this the deepest and longest downturn since the Great Depression. To
help stabilize financial markets, in October 2008 the US Congress established a
$700 billion Troubled Asset Relief Program (TARP). The government used some of
these funds to purchase equity in US banks and industrial corporations, much of
which had been returned to the government by early 2011. In January 2009 the US
Congress passed and President Barack OBAMA signed a bill providing an
additional $787 billion fiscal stimulus to be used over 10 years - two-thirds
on additional spending and one-third on tax cuts - to create jobs and to help
the economy recover. In 2010 and 2011, the federal budget deficit reached
nearly 9% of GDP. In 2012 the federal government reduced the growth of spending
and the deficit shrank to 7.6% of GDP. Wars in Iraq
and Afghanistan
required major shifts in national resources from civilian to military purposes
and contributed to the growth of the budget deficit and public debt. Through
2011, the direct costs of the wars totaled nearly $900 billion, according to US
government figures. US revenues from taxes and other sources are lower, as a
percentage of GDP, than those of most other countries. In March 2010, President
OBAMA signed into law the Patient Protection and Affordable Care Act, a health
insurance reform that was designed to extend coverage to an additional 32
million American citizens by 2016, through private health insurance for the
general population and Medicaid for the impoverished. Total spending on health
care - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in 2010. In
July 2010, the president signed the DODD-FRANK Wall Street Reform and Consumer
Protection Act, a law designed to promote financial stability by protecting
consumers from financial abuses, ending taxpayer bailouts of financial firms,
dealing with troubled banks that are "too big to fail," and improving
accountability and transparency in the financial system - in particular, by
requiring certain financial derivatives to be traded in markets that are
subject to government regulation and oversight. In December 2012, the Federal
Reserve Board (Fed) announced plans to purchase $85 billion per month of
mortgage-backed and Treasury securities in an effort to hold down long-term
interest rates, and to keep short term rates near zero until unemployment drops
below 6.5% or inflation rises above 2.5%. In late 2013, the Fed announced that
it would begin scaling back long-term bond purchases to $75 billion per month
in January 2014 and reduce them further as conditions warranted; the Fed,
however, would keep short-term rates near zero so long as unemployment and
inflation had not crossed the previously stated thresholds. Long-term problems
include stagnation of wages for lower-income families, inadequate investment in
deteriorating infrastructure, rapidly rising medical and pension costs of an
aging population, energy shortages, and sizable current account and budget
deficits.
Company Name AND Address
Company name: PHARMA-RX CHEMICAL CORPORATION
Address: 300 Interpace Parkway, Ste 150, Parsippany,
NJ 07054
- USA
Telephone: +1
973-917-1400
Fax: +1 973-917-1440
Website: www.pharma-rxchem.com
Company Summary
Corporate ID#: 0100474310
State: New Jersey
Judicial form: Corporation – Profit
Date incorporated: February
1, 1991
Stock: -
Value: -
Name of manager: David LEMESHOW
ACTIVITIES
& OPERATIONS
IST
Business:
Pharm-Rx Chemical Corporation engages in marketing and distribution of
chemicals in the pharmaceutical and dietary supplement industries.
The company was founded in 1991.
Office of the Foreign
Assets Control (OFAC):
The company is not listed on the OFAC list.
The Specially Designated Nationals (SDN) List is a publication of OFAC
which lists individuals and organizations with whom United States citizens and
permanent residents are prohibited from doing business.
Foreign suppliers
include:
SEE QINGDAO BRIGHT MOON SEAWEED GROUP CO., LTD
67 Haibin Yi
Road,Jiaonan, Qingdao, Shandong Sheng 266400 China
EIN: -
Staff: 4
Operations & branches:
At the headquarters, we
find the corporate office, on lease.
The address given on your
order:
Arco Warehouse, 61 Willet Street, Passaic,
NJ 07055
is a delivery address only.
SHAREHOLDERS & MANAGERS
Shareholders:
This is a private company.
Management:
David LEMESHOW is the President.
He has been in the Chemical Industry for over 32 years. After
getting his Bachelors of Science degree from the State University of New York
at Binghamton, he worked at BASF Corporation in both their Flavor and Fragrance
division (Fritzsche, Dodge & Olcott), and in their Fine Chemicals division
(Nutritional Ingredients & Knoll Fine Chemicals). Dave began at BASF
as an Analytical Methodology Chemist, and then moved to manager of Basic
Products for Flavors and Fragrances, and then promoted to field sales for their
Fine
Chemicals group. In 1991, Dave founded Pharm-Rx Chemical
Corporation.
Carlos DOUSSINAGUE is Vice President.
He graduated from the ESADE Business School
in Barcelona
with a degree in Business Administration. Carlos’ professional career has been dedicated
to Fine Chemical Ingredients since 1985, holding different positions in Europe,
South-East Asia, Latin America and the USA. He has developed an impressive
business network that has helped Pharm-Rx grow as one of the leading suppliers
to the industry since he joined the firm in 2001.
Ann SMITH is Secretary.
As far as we know, they are involved in other corporations, including:
Subsidiaries and
partnership:
None
FINANCIALS
In United States,
privately held corporations are not required to publish any financials.
On a direct call, nobody
accepted to answer our questions.
We sent a fax but no answer
received.
Outside sources (bank) gave
estimate sales for fiscal year ending February 2014 in the range of USD
400,000=
The business is said to be
profitable.
Banks: Chase Bank
LEGAL FILINGS
Legal filings
& complaints:
As of today date, there is no legal filing pending with the Courts.
Secured debts
summary (UCC):
1 UCC # 2177949 dated August 6, 2003